In antitrust law, a new theory circulating within the legal circles highlights the cross-market effects, particularly in relation to hospital mergers. For a significant period, antitrust implications of hospital mergers have been traditionally examined within the context of competition for patients within the same local market. The emerging theory broadens this perspective.
Coined as the “cross-market effects”, this new theory posits that mergers, even when they do not directly reduce competition within the same market, can still have anticompetitive outcomes if the entities involved enjoy dominant positions in their respective markets. This appears to be moving the focus of antitrust considerations beyond immediate market competition to potential effects across different markets.
This change in perspective can be seen as a response to the evolving complexities of modern markets, where entities, though operating within discrete but interconnected markets, can exert influence beyond their immediate sphere of operation.
What does this mean for future hospital mergers? The shift could mean that competition evaluations may go beyond just juxtaposing how hospitals compete for patients within the same local geographical market. It may imply layering these with considerations of how each entity competes not just for patients but also for inputs like professional medical personnel, medical and non-medical supplies, and complex partnership arrangements.
This nuanced approach could lead to more rigorous examination processes and possibly, more stringent enforcement of antitrust laws in the healthcare industry. With this looming possibility, legal professionals dealing with hospital mergers may need to expand their considerations during merger negotiations, and ensure compliance with broader and more inclusive antitrust implications.
For more detailed insights and analysis of this new Antitrust Theory: Cross-Market Effects, read more here.